MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

First Results from the Ixcellence Network® Survey: Botulinum Neurotoxin-A Usage and Training in Cervical Dystonia & Spastic Paresis

R. Bhidayasiri, K. Bahtia, L.J. Jacinto, TM. Chung, T. Landreau, C. Colosimo (Bangkok, Thailand)

Meeting: 2018 International Congress

Abstract Number: 105

Keywords: Botulinum toxin: Clinical applications: dystonia, Botulinum toxin: Clinical applications: spasticity

Session Information

Date: Saturday, October 6, 2018

Session Title: Education in Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To describe the current situation of training and practices among physicians using botulinum neurotoxin-A (BoNT-A) injections in the treatment of Cervical Dystonia (CD) and Spastic Paresis (SP).

Background: BoNT-A is commonly used as the first line treatment for CD and SP. However, proper administration of BoNT-A requires specific training and the effectiveness of BoNT-A treatment is highly dependent on the experience of clinicians.

Methods: A multidisciplinary Steering Committee designed a self-completion questionnaire on experience, training and confidence in different BoNT-A injection techniques and rehabilitation methods. The questionnaire was completed by 17 experts managing patients with SP and CD, selected among the Ixcellence Network®(IN) faculty. Here we present a preliminary analysis of their answers. These results will be supplemented by additional data (which will be available for the congress) from a database of more than 700 practitioners who participated in the IN courses.

Results: The questionnaire was completed by 17 physicians specialized in physical medicine and rehabilitation (9/17), neurology (7/17) and pediatric neurology (1/17), with an average experience of 22 years in their field and 18 years in BoNT-A injection. All received training prior to first injection, complete with dedicated sessions on guidance techniques: 15 on ultrasound (US), 11 on anatomical landmarks, 6 on electrostimulation (ES) and 7 on electromyography (EMG). In the respondents’ current practice, BoNT-A injection was performed without guidance by 14 of them. However, guidance techniques were also sometimes used: US (15/17), ES (11/17) and EMG (10/17). Fifteen physicians also received specific training on rehabilitation methods for SP (11), CD (1) or both (3). Overall, self-confidence in using injection techniques or rehabilitation methods was greater among physicians who had attended specific training.

Conclusions: Our preliminary results highlight the importance of BoNT-A training since most physicians adopt the method that they feel most comfortable in their routine practices. Moreover, attending specific courses was associated with greater self-confidence.

To cite this abstract in AMA style:

R. Bhidayasiri, K. Bahtia, L.J. Jacinto, TM. Chung, T. Landreau, C. Colosimo. First Results from the Ixcellence Network® Survey: Botulinum Neurotoxin-A Usage and Training in Cervical Dystonia & Spastic Paresis [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/first-results-from-the-ixcellence-network-survey-botulinum-neurotoxin-a-usage-and-training-in-cervical-dystonia-spastic-paresis/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/first-results-from-the-ixcellence-network-survey-botulinum-neurotoxin-a-usage-and-training-in-cervical-dystonia-spastic-paresis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley